Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glaucoma | 40 | 2023 | 1159 | 7.700 |
Why?
|
Visual Fields | 34 | 2024 | 1047 | 7.090 |
Why?
|
Visual Field Tests | 27 | 2024 | 383 | 3.520 |
Why?
|
Optic Disk | 12 | 2024 | 400 | 2.780 |
Why?
|
Nerve Fibers | 14 | 2023 | 687 | 2.180 |
Why?
|
Vision Disorders | 20 | 2024 | 1058 | 2.100 |
Why?
|
Glaucoma, Open-Angle | 16 | 2024 | 706 | 1.910 |
Why?
|
Tomography, Optical Coherence | 19 | 2024 | 2657 | 1.730 |
Why?
|
Artificial Intelligence | 9 | 2023 | 2214 | 1.650 |
Why?
|
Intraocular Pressure | 25 | 2024 | 1270 | 1.630 |
Why?
|
Retinal Ganglion Cells | 15 | 2024 | 770 | 1.540 |
Why?
|
Retina | 13 | 2024 | 2616 | 1.330 |
Why?
|
Ocular Hypertension | 3 | 2024 | 198 | 1.210 |
Why?
|
Liquid Crystals | 3 | 2012 | 20 | 1.170 |
Why?
|
Refractive Errors | 2 | 2017 | 142 | 1.100 |
Why?
|
Optic Nerve Diseases | 6 | 2023 | 327 | 0.750 |
Why?
|
Retinal Artery Occlusion | 1 | 2021 | 74 | 0.750 |
Why?
|
Retinal Vein Occlusion | 1 | 2021 | 137 | 0.710 |
Why?
|
Retinal Artery | 1 | 2017 | 111 | 0.580 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2019 | 719 | 0.580 |
Why?
|
Scotoma | 2 | 2020 | 139 | 0.570 |
Why?
|
Trabeculectomy | 3 | 2022 | 160 | 0.530 |
Why?
|
Luminescence | 2 | 2013 | 137 | 0.530 |
Why?
|
Strabismus | 3 | 2024 | 287 | 0.500 |
Why?
|
Cathode Ray Tube | 2 | 2012 | 2 | 0.490 |
Why?
|
Photic Stimulation | 3 | 2011 | 2025 | 0.490 |
Why?
|
Biological Specimen Banks | 6 | 2023 | 711 | 0.450 |
Why?
|
Pterygium | 2 | 2023 | 26 | 0.450 |
Why?
|
Registries | 11 | 2024 | 8089 | 0.440 |
Why?
|
Semiconductors | 1 | 2013 | 105 | 0.430 |
Why?
|
Organic Chemicals | 1 | 2013 | 211 | 0.430 |
Why?
|
Retinal Vessels | 2 | 2021 | 772 | 0.430 |
Why?
|
Contrast Sensitivity | 4 | 2022 | 244 | 0.400 |
Why?
|
Glaucoma, Angle-Closure | 2 | 2023 | 189 | 0.390 |
Why?
|
Retrospective Studies | 32 | 2024 | 77449 | 0.370 |
Why?
|
Blindness | 1 | 2015 | 617 | 0.370 |
Why?
|
Pseudotumor Cerebri | 2 | 2022 | 100 | 0.370 |
Why?
|
Computer Peripherals | 1 | 2010 | 38 | 0.360 |
Why?
|
Glaucoma Drainage Implants | 2 | 2022 | 116 | 0.360 |
Why?
|
Optic Neuritis | 2 | 2022 | 166 | 0.360 |
Why?
|
Electronics, Medical | 1 | 2009 | 71 | 0.350 |
Why?
|
Psychophysics | 1 | 2010 | 309 | 0.350 |
Why?
|
Light | 2 | 2013 | 1374 | 0.350 |
Why?
|
Neurophysiology | 1 | 2010 | 142 | 0.350 |
Why?
|
Vision, Ocular | 1 | 2012 | 464 | 0.340 |
Why?
|
Artifacts | 3 | 2023 | 1904 | 0.340 |
Why?
|
Psychology | 1 | 2010 | 356 | 0.330 |
Why?
|
Cross-Sectional Studies | 16 | 2024 | 25043 | 0.320 |
Why?
|
Pattern Recognition, Visual | 2 | 2011 | 824 | 0.310 |
Why?
|
Humans | 88 | 2024 | 744343 | 0.310 |
Why?
|
Recovery of Function | 1 | 2017 | 2925 | 0.300 |
Why?
|
Myopia | 2 | 2021 | 254 | 0.290 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2012 | 1534 | 0.280 |
Why?
|
Prosopagnosia | 3 | 2011 | 60 | 0.270 |
Why?
|
Disease Progression | 10 | 2022 | 13284 | 0.260 |
Why?
|
Neurosciences | 1 | 2010 | 348 | 0.260 |
Why?
|
Ophthalmia, Sympathetic | 1 | 2023 | 16 | 0.240 |
Why?
|
Aphakia | 1 | 2023 | 24 | 0.230 |
Why?
|
Macular Degeneration | 2 | 2022 | 980 | 0.230 |
Why?
|
Diabetic Retinopathy | 2 | 2024 | 1210 | 0.230 |
Why?
|
Visual Acuity | 5 | 2022 | 2530 | 0.230 |
Why?
|
Exotropia | 1 | 2024 | 55 | 0.230 |
Why?
|
Middle Aged | 27 | 2023 | 213383 | 0.220 |
Why?
|
Lacrimal Duct Obstruction | 1 | 2023 | 48 | 0.220 |
Why?
|
Photophobia | 1 | 2023 | 67 | 0.210 |
Why?
|
Algorithms | 7 | 2023 | 13881 | 0.210 |
Why?
|
Psychomotor Performance | 1 | 2011 | 1901 | 0.210 |
Why?
|
Dacryocystorhinostomy | 1 | 2023 | 72 | 0.210 |
Why?
|
Nasolacrimal Duct | 1 | 2023 | 74 | 0.210 |
Why?
|
Ophthalmologic Surgical Procedures | 2 | 2024 | 349 | 0.210 |
Why?
|
Epiretinal Membrane | 1 | 2022 | 68 | 0.210 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12261 | 0.200 |
Why?
|
Follow-Up Studies | 9 | 2024 | 39050 | 0.200 |
Why?
|
Aged | 21 | 2023 | 163280 | 0.200 |
Why?
|
Keratitis, Herpetic | 1 | 2022 | 81 | 0.200 |
Why?
|
Trigeminal Nerve Diseases | 1 | 2022 | 55 | 0.200 |
Why?
|
Corneal Dystrophies, Hereditary | 1 | 2022 | 81 | 0.190 |
Why?
|
Learning | 1 | 2011 | 1713 | 0.190 |
Why?
|
Graves Ophthalmopathy | 1 | 2023 | 117 | 0.190 |
Why?
|
Reproducibility of Results | 7 | 2023 | 19905 | 0.190 |
Why?
|
Botulinum Toxins, Type A | 1 | 2024 | 213 | 0.190 |
Why?
|
Microvessels | 2 | 2021 | 544 | 0.180 |
Why?
|
Phacoemulsification | 1 | 2022 | 149 | 0.180 |
Why?
|
Bayes Theorem | 4 | 2022 | 2309 | 0.180 |
Why?
|
Male | 29 | 2023 | 350118 | 0.180 |
Why?
|
Face | 4 | 2024 | 994 | 0.180 |
Why?
|
Glucose Intolerance | 1 | 2024 | 577 | 0.180 |
Why?
|
Burns, Chemical | 1 | 2021 | 159 | 0.170 |
Why?
|
Female | 30 | 2024 | 380194 | 0.170 |
Why?
|
Adult | 24 | 2024 | 214055 | 0.170 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3507 | 0.170 |
Why?
|
Time Factors | 7 | 2017 | 40075 | 0.160 |
Why?
|
Prediabetic State | 1 | 2024 | 499 | 0.160 |
Why?
|
Models, Biological | 1 | 2015 | 9583 | 0.160 |
Why?
|
Cataract Extraction | 1 | 2022 | 481 | 0.160 |
Why?
|
Emmetropia | 1 | 2017 | 6 | 0.150 |
Why?
|
Cataract | 1 | 2023 | 834 | 0.150 |
Why?
|
Eye Proteins | 1 | 2021 | 646 | 0.150 |
Why?
|
Low Tension Glaucoma | 1 | 2016 | 22 | 0.140 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2019 | 245 | 0.140 |
Why?
|
Reaction Time | 3 | 2012 | 2097 | 0.140 |
Why?
|
False Positive Reactions | 1 | 2019 | 981 | 0.140 |
Why?
|
Mendelian Randomization Analysis | 1 | 2021 | 967 | 0.140 |
Why?
|
Oculomotor Muscles | 3 | 2024 | 371 | 0.130 |
Why?
|
Cytoskeletal Proteins | 1 | 2021 | 1364 | 0.130 |
Why?
|
Neurodegenerative Diseases | 1 | 2024 | 1061 | 0.130 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12245 | 0.130 |
Why?
|
Retinal Neurons | 1 | 2015 | 66 | 0.120 |
Why?
|
Software | 2 | 2023 | 4443 | 0.120 |
Why?
|
ROC Curve | 2 | 2023 | 3527 | 0.120 |
Why?
|
Genetic Markers | 1 | 2020 | 2634 | 0.120 |
Why?
|
Multifactorial Inheritance | 1 | 2021 | 1194 | 0.110 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15540 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5751 | 0.110 |
Why?
|
Lipid Metabolism | 1 | 2021 | 1889 | 0.110 |
Why?
|
Glycoproteins | 1 | 2021 | 2263 | 0.110 |
Why?
|
Young Adult | 9 | 2021 | 56430 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1738 | 0.100 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2022 | 1209 | 0.100 |
Why?
|
Handwriting | 1 | 2011 | 28 | 0.100 |
Why?
|
Color | 1 | 2012 | 307 | 0.100 |
Why?
|
Genetic Loci | 1 | 2020 | 2575 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2019 | 6365 | 0.090 |
Why?
|
Aged, 80 and over | 6 | 2021 | 57776 | 0.090 |
Why?
|
Memory, Long-Term | 1 | 2011 | 64 | 0.090 |
Why?
|
Insulin Resistance | 1 | 2024 | 3864 | 0.090 |
Why?
|
Calibration | 1 | 2012 | 816 | 0.090 |
Why?
|
Aging | 2 | 2020 | 8664 | 0.090 |
Why?
|
Proteomics | 1 | 2023 | 3638 | 0.090 |
Why?
|
Risk Factors | 8 | 2023 | 72290 | 0.090 |
Why?
|
Reoperation | 3 | 2024 | 4201 | 0.080 |
Why?
|
Medicaid | 1 | 2022 | 2736 | 0.080 |
Why?
|
Adolescent | 9 | 2024 | 85781 | 0.080 |
Why?
|
Motion | 1 | 2012 | 798 | 0.080 |
Why?
|
Cohort Studies | 5 | 2024 | 40561 | 0.080 |
Why?
|
Psychometrics | 1 | 2017 | 3002 | 0.080 |
Why?
|
Optics and Photonics | 1 | 2009 | 321 | 0.080 |
Why?
|
Population Surveillance | 1 | 2018 | 2616 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2020 | 13989 | 0.070 |
Why?
|
Computer Simulation | 2 | 2011 | 6196 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15076 | 0.070 |
Why?
|
Infant | 3 | 2023 | 35136 | 0.070 |
Why?
|
Genomics | 1 | 2021 | 5720 | 0.070 |
Why?
|
Sex Factors | 1 | 2019 | 10397 | 0.070 |
Why?
|
Visual Perception | 2 | 2011 | 1420 | 0.060 |
Why?
|
Child, Preschool | 3 | 2024 | 41006 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2023 | 25625 | 0.060 |
Why?
|
Memory Disorders | 1 | 2011 | 1184 | 0.060 |
Why?
|
Models, Theoretical | 2 | 2020 | 3589 | 0.060 |
Why?
|
Retinal Hemorrhage | 1 | 2023 | 96 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 20947 | 0.050 |
Why?
|
Intubation | 1 | 2023 | 141 | 0.050 |
Why?
|
Vision, Binocular | 1 | 2024 | 213 | 0.050 |
Why?
|
Visual Cortex | 1 | 2010 | 1149 | 0.050 |
Why?
|
Child | 4 | 2024 | 77709 | 0.050 |
Why?
|
Sclera | 1 | 2023 | 200 | 0.050 |
Why?
|
Language | 1 | 2011 | 1471 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 15519 | 0.050 |
Why?
|
Methylprednisolone | 1 | 2022 | 387 | 0.050 |
Why?
|
Conjunctiva | 1 | 2023 | 494 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2024 | 63114 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 976 | 0.040 |
Why?
|
Penetrance | 1 | 2021 | 381 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2020 | 588 | 0.040 |
Why?
|
Retinal Pigment Epithelium | 1 | 2022 | 302 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15165 | 0.040 |
Why?
|
Decompression, Surgical | 1 | 2023 | 594 | 0.040 |
Why?
|
United States | 5 | 2023 | 69872 | 0.040 |
Why?
|
Prospective Studies | 4 | 2023 | 53288 | 0.040 |
Why?
|
Prednisone | 1 | 2022 | 1574 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2022 | 642 | 0.040 |
Why?
|
Suture Techniques | 1 | 2022 | 798 | 0.040 |
Why?
|
Fluorescein Angiography | 1 | 2021 | 940 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2023 | 21746 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1157 | 0.040 |
Why?
|
Eye | 1 | 2021 | 729 | 0.040 |
Why?
|
Vision Tests | 1 | 2017 | 167 | 0.040 |
Why?
|
Psychotropic Drugs | 1 | 2022 | 894 | 0.030 |
Why?
|
Mutation | 1 | 2021 | 29786 | 0.030 |
Why?
|
Cornea | 1 | 2023 | 1524 | 0.030 |
Why?
|
Regression Analysis | 1 | 2022 | 6459 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3305 | 0.030 |
Why?
|
Glucose | 1 | 2024 | 4397 | 0.030 |
Why?
|
Hemorrhage | 1 | 2023 | 3461 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3339 | 0.020 |
Why?
|
Animals | 3 | 2019 | 168757 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2022 | 1901 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8340 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2022 | 15295 | 0.020 |
Why?
|
Insurance, Health | 1 | 2022 | 2494 | 0.020 |
Why?
|
Linear Models | 1 | 2020 | 5952 | 0.020 |
Why?
|
Stents | 1 | 2021 | 3280 | 0.020 |
Why?
|
Chronic Disease | 1 | 2024 | 9146 | 0.020 |
Why?
|
Self-Assessment | 1 | 2011 | 390 | 0.020 |
Why?
|
Neuropsychological Tests | 2 | 2011 | 6993 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 4042 | 0.020 |
Why?
|
Cognition | 1 | 2024 | 6770 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15226 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 8987 | 0.020 |
Why?
|
Kidney | 1 | 2021 | 7186 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14722 | 0.020 |
Why?
|
Models, Statistical | 1 | 2016 | 5102 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 8949 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29063 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16365 | 0.010 |
Why?
|
Concepts
(207)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(57)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_